| Short‐term BMP‐2 expression is sufficient for in vivo osteochondral differentiation of mesenchymal stem cells D Noël, D Gazit, C Bouquet, F Apparailly, C Bony, P Plence, V Millet, ... Stem cells 22 (1), 74-85, 2004 | 351 | 2004 |
| Exogenously regulated stem cell-mediated gene therapy for bone regeneration IK Moutsatsos, G Turgeman, S Zhou, BG Kurkalli, G Pelled, L Tzur, ... Molecular Therapy 3 (4), 449-461, 2001 | 329 | 2001 |
| Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy G Turgeman, D D. Pittman, R Müller, B Gowda Kurkalli, S Zhou, G Pelled, ... The journal of gene medicine 3 (3), 240-251, 2001 | 318 | 2001 |
| Neotendon formation induced by manipulation of the Smad8 signalling pathway in mesenchymal stem cells A Hoffmann, G Pelled, G Turgeman, P Eberle, Y Zilberman, H Shinar, ... The Journal of clinical investigation 116 (4), 940-952, 2006 | 311 | 2006 |
| Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: a novel cell‐mediated gene therapy D Gazit, G Turgeman, P Kelley, E Wang, M Jalenak, Y Zilberman, ... The journal of gene medicine 1 (2), 121-133, 1999 | 308 | 1999 |
| Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells S Zhou, G Turgeman, SE Harris, DC Leitman, BS Komm, PVN Bodine, ... Molecular Endocrinology 17 (1), 56-66, 2003 | 189 | 2003 |
| Stem cells as vehicles for orthopedic gene therapy Y Gafni, G Turgeman, M Liebergal, G Pelled, Z Gazit, D Gazit Gene Therapy 11 (4), 417-426, 2004 | 166 | 2004 |
| Gene therapy platform for bone regeneration using an exogenously regulated, AAV-2-based gene expression system Y Gafni, G Pelled, Y Zilberman, G Turgeman, F Apparailly, H Yotvat, ... Molecular Therapy 9 (4), 587-595, 2004 | 161 | 2004 |
| Systemically administered rhBMP‐2 promotes MSC activity and reverses bone and cartilage loss in osteopenic mice G Turgeman, Y Zilberman, S Zhou, P Kelly, IK Moutsatsos, YP Kharode, ... Journal of cellular biochemistry 86 (3), 461-474, 2002 | 159 | 2002 |
| Mesenchymal stem cells increase hippocampal neurogenesis and counteract depressive-like behavior M Tfilin, E Sudai, A Merenlender, I Gispan, G Yadid, G Turgeman Molecular psychiatry 15 (12), 1164-1175, 2010 | 142 | 2010 |
| Murine spinal fusion induced by engineered mesenchymal stem cells that conditionally express bone morphogenetic protein—2 A Hasharoni, Y Zilberman, G Turgeman, GA Helm, M Liebergall, D Gazit Journal of Neurosurgery: Spine 3 (1), 47-52, 2005 | 132 | 2005 |
| The T-box transcription factor Brachyury mediates cartilage development in mesenchymal stem cell line C3H10T1/2 A Hoffmann, S Czichos, C Kaps, D Bächner, H Mayer, Y Zilberman, ... Journal of Cell Science 115 (4), 769-781, 2002 | 129 | 2002 |
| Mesenchymal stem cells for bone gene therapy and tissue engineering G Pelled, G Turgeman, H Aslan, Z Gazit, D Gazit Current Pharmaceutical Design 8 (21), 1917-1928, 2002 | 103 | 2002 |
| Molecular imaging of the skeleton: Quantitative real‐time bioluminescence monitoring gene expression in bone repair and development I Bar, Y Zilberman, E Zeira, E Galun, A Honigman, G Turgeman, ... Journal of Bone and Mineral Research 18 (3), 570-578, 2003 | 82 | 2003 |
| Methods and compositions for enhancing cartilage repair D Gazit, Y Zilberman, G Turgeman, G Pelled, G Gross, S Czichos, ... US Patent 6,849,255, 2005 | 78 | 2005 |
| Recombinant TGF‐β1 stimulates bone marrow osteoprogenitor cell activity and bone matrix synthesis in osteopenic, old male mice D Gazit, Y Zilberman, G Turgeman, S Zhou, A Kahn Journal of Cellular Biochemistry 73 (3), 379-389, 1999 | 67 | 1999 |
| S-adenosyl methionine prevents ASD like behaviors triggered by early postnatal valproic acid exposure in very young mice A Ornoy, L Weinstein-Fudim, M Tfilin, Z Ergaz, J Yanai, M Szyf, ... Neurotoxicology and teratology 71, 64-74, 2019 | 50 | 2019 |
| Cell-mediated gene therapy for bone formation and regeneration. G Turgeman, H Aslan, Z Gazit, D Gazit Current opinion in molecular therapeutics 4 (4), 390-394, 2002 | 45 | 2002 |
| Transplantation of mesenchymal stem cells reverses behavioural deficits and impaired neurogenesis caused by prenatal exposure to valproic acid N Gobshtis, M Tfilin, M Wolfson, VE Fraifeld, G Turgeman Oncotarget 8 (11), 17443, 2017 | 42 | 2017 |
| The therapeutic potential of mesenchymal stem cells in Alzheimer's disease: converging mechanisms G Turgeman Neural regeneration research 10 (5), 698-699, 2015 | 41 | 2015 |
